0001437749-23-004940.txt : 20230228
0001437749-23-004940.hdr.sgml : 20230228
20230228170907
ACCESSION NUMBER: 0001437749-23-004940
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230224
FILED AS OF DATE: 20230228
DATE AS OF CHANGE: 20230228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yoder Stephen S.
CENTRAL INDEX KEY: 0001645577
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37471
FILM NUMBER: 23687069
MAIL ADDRESS:
STREET 1: LISE-MEITNER-STRASSE 30
STREET 2: C/O PIERIS PHARMACEUTICALS, INC.
CITY: FREISING-WEIHENSTEPHAN
STATE: 2M
ZIP: 85354
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PIERIS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001583648
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300784346
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-246-8998
MAIL ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
FORMER COMPANY:
FORMER CONFORMED NAME: Marika Inc.
DATE OF NAME CHANGE: 20130805
4
1
rdgdoc.xml
230228 FORM 4 (YODER)
X0306
4
2023-02-24
0001583648
PIERIS PHARMACEUTICALS, INC.
PIRS
0001645577
Yoder Stephen S.
C/O PIERIS PHARMACEUTICALS, INC.
225 FRANKLIN STREET, 26TH FLOOR
BOSTON
MA
02110
1
1
Chief Executive Officer
Stock Option (Right to buy)
1.39
2023-02-24
4
A
0
634021
0
A
2033-02-24
Common Stock
634021
634021
D
The option vests as to 25% of the option shares on February 24, 2024 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.
/s/ Ahmed Mousa, Attorney-in-fact
2023-02-28